Mari Kogo

9PUBLICATIONS
29CO-AUTHORS
Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 05, 2026
Factors Associated With Loop Diuretic De-escalation in Patients With Acute Decompensated Heart Failure: The Influence of Guideline Directed Medical Therapy Initiation.

Satoshi Hanazawa, Noriko Kohyama, Erika Iwasaki

|Jul 15, 2025
Factors Associated with Initial Treatment Failure in Inpatients with Exacerbation of Chronic Obstructive Pulmonary Disease: A Cohort Study.

Noriko Kohyama, Kuniaki Hirai, Hironori Sagara

|Dec 26, 2024
Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment.

Miki Takenaka Sato, Takuya Araki, Hideaki Yashima

|Nov 20, 2024
Cost-effectiveness analysis of first line pembrolizumab monotherapy for high programmed cell death ligand 1 expressed, advanced non-small cell lung cancer in Japan.

Kazuki Tomura, Hiroyuki Sakamaki, Shuichi Nawata

|Aug 28, 2024
Relationship between the combination of platelet count and neutrophil-lymphocyte ratio and prognosis of patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective cohort study.

Saeko Kashimura, Miki Sato, Takahito Inagaki

|Nov 26, 2022
Prognostic model for overall survival that includes the combination of platelet count and neutrophil-lymphocyte ratio within the first six weeks of sunitinib treatment for metastatic renal cell carcinoma.

Miki Takenaka Sato, Ayuki Ida, Yuki Kanda

Pageof 2

Frequent Collaborators

5 joint publications

Miki Takenaka Sato

5 joint publications

Noriko Kohyama

2 joint publications

Tatsuya Kurihara

2 joint publications

Masayuki Ohbayashi